www.fdanews.com/articles/176767-nuvasive-launches-attrax-putty
NuVasive Launches AttraX Putty
May 23, 2016
San Diego, Calif.-based NuVasive has launched its AttraX putty in the U.S., the devicemaker announced Monday, expanding the company’s existing biologics portfolio.
The putty is designed for use as a bone autograft extender in posterolateral spine surgeries and features a “biotextured surface” to promote bone regeneration, according to a company statement.
The company received FDA clearance for the putty in October 2015. — Anisa Jibrell